Recruited 6 months ago to lead the US vaccine strategy, Belgian-Moroccan Moncef Slaoui resigned Tuesday January 12 at the request of the Biden team. Dr Slaoui will step down in a month, after leading the unprecedented effort of the US government to develop a safe and effective vaccine against Covid-19 before the end of 2020. The Moroccan-American immunologist had previously announced his intention to resign a once two vaccines and two therapies for Covid-19 were on the market, a goal that was achieved last month with the approval by U.S. health officials of Moderna and Pfizer’s vaccines. Although the vaccination campaign has not been as rapid as expected in the United States, the speed of vaccine development, overseen by Dr Slaoui, has exceeded expectations. Two vaccines have been authorized in the United States with 95% effectiveness against the virus in less than a year.
Trending
- Kenya starts talks with Ethiopia for more electricity
- Afreximbank launches $3 billion revolving facility for oil players
- Four Kenyans wanted by Nigerian authorities for CBEX hack
- IMF tough rules for Kenya’s new loan
- ARC Ltd and Klapton Re join forces to expand climate insurance across Africa
- Investors snub Ethio Telecom’s IPO, taking only 10.7 percent of shares offered
- Ruto bags $823 million in China
- Kenya’s KCB, Equity Bank to sell 30 percent stake in Congo subsidiaries